Aisling Capital Management LP Long-Term Concentrated

CIK: 0001766721 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: May 9, 2023

Total Value ($000): $207,812 (100.0% shares, 0.0% debt)

Holdings (16)

BBIO BridgeBio Pharma Inc. (BBIO) 48.4%

Value ($000) $100,610 Shares 6,068,125 Est. Cost $40.43 Unrealized -71.2%

BMEA Biomea Fusion Inc. (BMEA) 11.9%

Value ($000) $24,769 Shares 798,757 Est. Cost $17.65 Unrealized -29.6%

— Verona Pharma plc (VRNA) 10.8%

Value ($000) $22,396 Shares 1,115,352 Est. Cost $7.38 Unrealized —

SNDX Syndax Pharmaceuticals, Inc. (SNDX) 10.4%

Value ($000) $21,648 Shares 1,025,000 Est. Cost $10.24 Unrealized +142.9%

GLUE Monte Rosa Therapeutics Inc. (GLUE) 5.5%

Value ($000) $11,469 Shares 1,472,331 Est. Cost $20.37 Unrealized -65.9%

— Elevation Oncology Inc. (ELEV) 2.6%

Value ($000) $5,386 Shares 2,834,910 Est. Cost $13.57 Unrealized —

— Reneo Pharmaceuticals Inc. (RPHM) 2.5%

Value ($000) $5,299 Shares 886,075 Est. Cost $9.33 Unrealized —

NUVB Nuvation Bio Inc. (NUVB) 2.0%

Value ($000) $4,218 Shares 2,541,009 Est. Cost $11.18 Unrealized -81.9%

ACRS Aclaris Theraputics Inc. (ACRS) 1.7%

Value ($000) $3,515 Shares 434,455 Est. Cost $10.31 Unrealized +23.1%

— Poseida Therapeutics Inc. (PSTX) 1.5%

Value ($000) $3,213 Shares 1,043,267 Est. Cost $8.87 Unrealized —

— Spruce Biosciences, Inc. (SPRB) 1.3%

Value ($000) $2,664 Shares 1,205,511 Est. Cost $24.31 Unrealized —

— AVROBIO, Inc. (AVRO) 0.5%

Value ($000) $1,010 Shares 1,009,779 Est. Cost $16.72 Unrealized —

— Aeglea Biotherapeutics Inc. (AGLE) 0.2%

Value ($000) $490 Shares 1,691,151 Est. Cost $8.00 Unrealized —

— Viracta Therapeutics Inc. (VIRX) 0.2%

Value ($000) $459 Shares 288,571 Est. Cost $11.34 Unrealized —

— Atreca Inc. (BCEL) 0.2%

Value ($000) $442 Shares 387,653 Est. Cost $18.84 Unrealized —

— Marker Therapeutics, Inc. (MRKR) 0.1%

Value ($000) $223 Shares 314,286 Est. Cost $4.35 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BBIO	BridgeBio Pharma Inc. (BBIO)	6,068,125	$100,610	48.4%	$40.43	-71.2%	COM	10806X102
BMEA	Biomea Fusion Inc. (BMEA)	798,757	$24,769	11.9%	$17.65	-29.6%	COM	09077A106
—	Verona Pharma plc (VRNA)	1,115,352	$22,396	10.8%	$7.38	—	SPONSORED ADS	925050106
SNDX	Syndax Pharmaceuticals, Inc. (SNDX)	1,025,000	$21,648	10.4%	$10.24	+142.9%	COM	87164F105
GLUE	Monte Rosa Therapeutics Inc. (GLUE)	1,472,331	$11,469	5.5%	$20.37	-65.9%	COM	61225M102
—	Elevation Oncology Inc. (ELEV)	2,834,910	$5,386	2.6%	$13.57	—	COM	28623U101
—	Reneo Pharmaceuticals Inc. (RPHM)	886,075	$5,299	2.5%	$9.33	—	COM	75974E103
NUVB	Nuvation Bio Inc. (NUVB)	2,541,009	$4,218	2.0%	$11.18	-81.9%	COM CL A	67080N101
ACRS	Aclaris Theraputics Inc. (ACRS)	434,455	$3,515	1.7%	$10.31	+23.1%	COM	00461U105
—	Poseida Therapeutics Inc. (PSTX)	1,043,267	$3,213	1.5%	$8.87	—	COM	73730P108
—	Spruce Biosciences, Inc. (SPRB)	1,205,511	$2,664	1.3%	$24.31	—	COM	85209E109
—	AVROBIO, Inc. (AVRO)	1,009,779	$1,010	0.5%	$16.72	—	COM	05455M100
—	Aeglea Biotherapeutics Inc. (AGLE)	1,691,151	$490	0.2%	$8.00	—	COM	00773J103
—	Viracta Therapeutics Inc. (VIRX)	288,571	$459	0.2%	$11.34	—	COM	92765F108
—	Atreca Inc. (BCEL)	387,653	$442	0.2%	$18.84	—	CL A COM	04965G109
—	Marker Therapeutics, Inc. (MRKR)	314,286	$223	0.1%	$4.35	—	COM	57055L107